Regent Pacific Group Ltd (hkse:00575) Share Price

Company Profile

Business description
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
Contact
5 Queen's Road Central
8th Floor, Henley Building
Hong Kong
HKG
T: +852 25146111
https://www.endurancerp.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
17

Recommended

Our view on the first results as a publicly traded company.

Nicolas Owens | 21 October 2026

A new ASX heavyweight with coal, copper and trading exposure.

Jon Mills, CFA | 20 October 2026

We’ll be watching Muse agent adoption, revenue growth, and more.

Malik Ahmed Khan, CFA | 20 October 2026

Index	Last price	Change	% Change
All Ordinaries	8,956.60	12.40	0.14%
CAC 40	7,908.59	70.10	0.89%
DAX 40	25,600.02	295.60	1.17%
Dow JONES (US)	52,495.88	529.85	1.02%
FTSE 100	10,759.43	26.43	0.25%
HKSE	23,651.87	215.87	-0.90%
NASDAQ	26,424.82	6.07	-0.02%
Nikkei 225	64,621.24	545.82	0.85%
NZX 50 Index	13,761.29	129.60	0.95%
S&P 500	7,712.57	0.00	0.00%
S&P/ASX 200	8,831.30	14.40	0.16%
SSE Composite Index	3,713.03	22.34	-0.60%